Drug profile · INN
levomilnacipran
LEVOMILNACIPRAN
levomilnacipran (LEVOMILNACIPRAN) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — levomilnacipran
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
levomilnacipran (LEVOMILNACIPRAN) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is levomilnacipran?
levomilnacipran (LEVOMILNACIPRAN) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for levomilnacipran?
LEVOMILNACIPRAN is a marketed brand name for levomilnacipran. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levomilnacipran?
levomilnacipran has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.